OTHER CURRENT LIABILITIES	6 Months Ended
Jun. 30, 2013
OTHER CURRENT LIABILITIES [Text Block]	6. OTHER CURRENT LIABILITIES On June 24, 2013, the Company issued a promissory note to a related party of the Company in the aggregate principal amount of up to $238,411. The sum of $128,411 was advanced on June 24, 2013 – of that amount, $28,411 was applied to repay in full the principal and accrued interest outstanding under a previously-issued promissory note held by the lender, and the balance of $100,000 was allocated to working capital. The remaining $110,000 in principal was advanced under the promissory note subsequent to the end of the quarter for working capital purposes. The promissory note matures on June 24, 2014 and bears an interest rate of 20% per annum. In connection with this financing, the Company issued 953,644 common stock purchase warrants to the lender, each exercisable for a period of three years to purchase one share of the Company’s common stock at an exercise price of $0.02. Due to its deminimus nature, the value of the warrant in the amount of $13,246 was expensed as interest expense during the quarter ended June 30, 2013 within the condensed consolidated statements of operations.

OTHER CURRENT LIABILITIES

6 Months Ended

Jun. 30, 2013

6. OTHER CURRENT LIABILITIES

On June 24, 2013, the Company issued a promissory note to a related party of the Company in the aggregate principal amount of up to $238,411. The sum of $128,411 was advanced on June 24, 2013 – of that amount, $28,411 was applied to repay in full the principal and accrued interest outstanding under a previously-issued promissory note held by the lender, and the balance of $100,000 was allocated to working capital. The remaining $110,000 in principal was advanced under the promissory note subsequent to the end of the quarter for working capital purposes. The promissory note matures on June 24, 2014 and bears an interest rate of 20% per annum. In connection with this financing, the Company issued 953,644 common stock purchase warrants to the lender, each exercisable for a period of three years to purchase one share of the Company’s common stock at an exercise price of $0.02. Due to its deminimus nature, the value of the warrant in the amount of $13,246 was expensed as interest expense during the quarter ended June 30, 2013 within the condensed consolidated statements of operations.